Clinical Trials Directory

Trials / Completed

CompletedNCT02810158

Mass Spectral Fingerprinting in Obstructive Sleep Apnoea

Diagnosis of Obstructive Sleep Apnoea by Selective Secondary Electrospray Ionization - Mass Spectrometry (SESIMS)

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To answer the question whether a previously detected breath profile in patients suffering from obstructive sleep apnoea (OSA) can be found in a cohort of patients with suspected OSA using mass spectrometry (validation study).

Conditions

Timeline

Start date
2016-06-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2016-06-22
Last updated
2018-10-19

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02810158. Inclusion in this directory is not an endorsement.

Mass Spectral Fingerprinting in Obstructive Sleep Apnoea (NCT02810158) · Clinical Trials Directory